WDB coco CO.,LTD. Logo

WDB coco CO.,LTD.

CRO for pharma & med devices specializing in safety info, PMS & full lifecycle support.

7079 | T

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
Japan
Address:
中央区晴海一丁目8−11
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

WDB coco CO., LTD. is a Contract Research Organization (CRO) that provides specialized support services for the pharmaceutical and medical device industries. The company's core expertise lies in safety information management (pharmacovigilance) and post-marketing surveillance (PMS). Its comprehensive service portfolio also encompasses support for clinical research, clinical trials, regulatory affairs and quality assurance (RA/QA), and the development of medical devices. WDB coco focuses on delivering operational support throughout the product lifecycle, from development and regulatory submission to post-marketing activities.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-06-30 02:44
Governance Information
内部統制報告書-第42期(2024/04/01-2025/03/31)
Japanese 23.8 KB
2025-06-30 02:39
Regulatory News Service
確認書
Japanese 8.7 KB
2025-06-30 02:34
Annual Report
有価証券報告書-第42期(2024/04/01-2025/03/31)
Japanese 852.8 KB
2025-06-25 07:27
Post-Annual General Meeting Information
臨時報告書
Japanese 23.7 KB
2024-11-14 02:00
Report Publication Announcement
確認書
Japanese 8.7 KB
2024-11-14 01:54
Interim Report
半期報告書-第42期(2024/04/01-2025/03/31)
Japanese 178.8 KB
2024-06-28 04:07
Regulatory News Service
内部統制報告書-第41期(2023/04/01-2024/03/31)
Japanese 22.8 KB
2024-06-28 03:56
Regulatory News Service
確認書
Japanese 8.7 KB
2024-06-28 03:50
Annual Report
有価証券報告書-第41期(2023/04/01-2024/03/31)
Japanese 846.0 KB
2024-06-24 03:30
Post-Annual General Meeting Information
臨時報告書
Japanese 23.5 KB
2024-02-14 02:03
Regulatory News Service
確認書
Japanese 8.7 KB
2024-02-14 01:50
Quarterly Report
四半期報告書-第41期第3四半期(2023/10/01-2023/12/31)
Japanese 143.4 KB
2023-11-14 01:44
Regulatory News Service
確認書
Japanese 8.7 KB
2023-11-14 01:35
Quarterly Report
四半期報告書-第41期第2四半期(2023/07/01-2023/09/30)
Japanese 178.7 KB
2023-08-10 03:59
Report Publication Announcement
確認書
Japanese 8.7 KB

Automate Your Workflow. Get a real-time feed of all WDB coco CO.,LTD. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for WDB coco CO.,LTD. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Developing novel cancer immunotherapies, including peptide vaccines and iPS-NKT cell therapies.
Japan 4594
Brilliant Future AB Logo
A data-driven survey platform to measure and improve employee & customer experiences.
Sweden BRILL
b-style holdings,Inc. Logo
Offers flexible staffing for homemakers and specialized recruitment for skilled professionals.
Japan 302A
BTS Group Logo
Helps organizations execute strategy via experiential learning for leadership and sales teams.
Sweden BTS
B.U Technology Logo
Commercializes university research via IP management, licensing, and new venture creation.
South Korea 230980
Advancing high-grade copper and precious metal projects from discovery to production.
Canada N/A
Cantargia Logo
Develops antibody treatments targeting IL1RAP for cancer and autoimmune/inflammatory diseases.
Sweden CANTA
Captor Therapeutics S.A. Logo
Developing TPD therapeutics for oncology and autoimmune diseases with its Optigrade™ platform.
Poland CTX
Offers one-stop BPO, CRM, and staffing for admin, manufacturing, and logistics.
Japan 6070
Carna Biosciences, Inc. Logo
Develops kinase inhibitor drugs for oncology/autoimmune diseases & offers discovery support services.
Japan 4572

Talk to a Data Expert

Have a question? We'll get back to you promptly.